Why Regulators Focus on Burkholderia cepacia Complex Identification in Pharmaceuticals?
Why Regulators Focus on Burkholderia cepacia Complex Identification in Pharmaceuticals Why Regulators Focus on Burkholderia cepacia Complex Identification in Pharmaceuticals In pharmaceutical microbiology, very few microorganisms attract the same level of regulatory attention as Burkholderia cepacia complex (BCC) . Regulators do not focus on BCC because it is frequently detected, but because when it is missed, the consequences can directly impact patient safety. Repeated global product recalls, severe patient infections, and failures of traditional control strategies have established BCC as a high-risk, high-impact organism , particularly in non-sterile pharmaceutical products. Table of Contents Introduction Scientific Rationale Behind Regulatory Focus Regulatory Expectations and References Principle of BCC Identification Procedure Overview Identification Logic & Process Flow Risk-Based Failure Probability Practical Laboratory Scenarios Common...
